Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-4.46M.
ENTERPRISE VALUE (EV)
$-4.46M
Bone Biologics Corporation
Market Cap
$878396.00
Enterprise Value (EV)
$-4.46M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Bone Biologics Corporation (BBLG) | $878396.00 | $-4.46M |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A |
| CDT Equity Inc. (CDT)vs › | $707297.00 | $971.28M |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | $2.17M |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | $9.70M |
| HCW Biologics Inc. (HCWB)vs › | $570131.00 | $6.39M |
Market Cap
$878396.00
Total Debt
$0.00
Cash
$5.33M
Enterprise Value
$-4.46M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
